Capstone Headwaters Advises Revolutionary Medical Devices, Inc. on its Sale to Vyaire

June 8, 2018

BOSTON, MA – Capstone Headwaters advised Revolutionary Medical Devices, Inc. (RMD), a maker of innovate products for airway management, focused on significantly improving patient outcomes, on its sale to Vyaire Medical Inc., the healthcare industry’s dedicated “breathing company”. Terms of the transaction were not disclosed.

RMD’s main product, the SuperNO2VA™ device, is a complete noninvasive nasal PAP ventilation system designed for use in the treatment of respiratory insufficiency from collapse of the airway during or after sedation, or during the intubation process. The SuperNO2VA™ system effectively opens the upper airway, maintains patency, and allows the anesthesiologist to effectively ventilate the patient. It is designed to reduce the likelihood of respiratory compromise via perioperative hypoxemia, particularly with “high risk” patients who may be presented with difficult airways.

Read More

Industry: